Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP) [Phase 3]
Phase 3 trial comparing Cethromycin with Clarithromycin for community-acquired pneumonia has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia [Phase 3]
This Phase 3 trial compares the safety and efficacy of cethromycin versus clarithromycin for community-acquired pneumonia, with results post…
-
CLINICAL_TRIALS trial_result · 2010-02-19Clinical Trial Update: Sleep Apnea Syndrome and Community Acquired Pneumonia
A completed clinical trial sponsored by Hospital Universitario San Juan de Alicante investigated Sleep Apnea Syndrome with polygraphy and it…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia [Phase 2]
Phase 2 safety and efficacy study of an oxazolidinone to treat community-acquired pneumonia; trial completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Helmet Continuous Positive Airway Pressure Versus Oxygen Venturi in Acute Respiratory Failure in CAP: CAPOVeRSO [NA]
A terminated clinical trial comparing helmet continuous positive airway pressure to oxygen Venturi in acute respiratory failure due to commu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia [Phase 2]
A Phase 2 clinical trial comparing nemonoxacin to levofloxacin in adults with community-acquired pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-02Clinical Trial Update: Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia [Phase 3]
A Phase 3 Japanese study evaluating telithromycin for pediatric community-acquired pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Cotrimoxazole Versus Amoxicillin in the Treatment of Community Acquired Pneumonia in Children Aged 2-59 Months [Phase 3]
A Phase 3 randomized trial comparing cotrimoxazole with amoxicillin for community-acquired pneumonia in children aged 2-59 months has comple…
-
FDA approval · 2009-05-14FDA Approved: CEFDINIR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for CEFDINIR (cefdinir) submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-11Clinical Trial Update: Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors [Phase 4]
Phase 4 trial evaluating efficacy and safety of moxifloxacin for treating community-acquired pneumonia with aspiration factors; current stat…
-
FDA approval · 2009-03-05FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for Amoxicillin and Clavulanate Potassium, a generic antibiotic (…
-
FDA approval · 2009-03-04FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
FDA approves a supplemental application for Clarithromycin from Sandoz Inc, granting approval to a generic version under an ANDA.
-
CLINICAL_TRIALS research · 2009-02-27Clinical Trial Update: Usefulness of Microbiological Tests in Community-Acquired Pneumonia
Clinical trial update assessing the usefulness of microbiological tests in diagnosing community-acquired pneumonia.
-
CLINICAL_TRIALS trial_result · 2009-01-19Clinical Trial Update: Community Acquired Pneumonia in Telemark and Ostfold
This document reports a completed clinical trial in Telemark and Ostfold assessing treatment for Community Acquired Pneumonia. The sponsor i…
-
CLINICAL_TRIALS trial_result · 2009-01-09Clinical Trial Update: Comparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia [Phase 2]
Completed Phase 2 clinical trial update reporting results of a study comparing NXL103 to a comparator in adults with community-acquired pneu…
-
CLINICAL_TRIALS trial_result · 2008-09-29Clinical Trial Update: Efficacy Studies of Corticosteroid Therapy in Community-Acquired Pneumonia [Phase 3]
This Phase 3 clinical trial update reports on efficacy studies of corticosteroid therapy for community-acquired pneumonia, and the study sta…
-
FDA approval · 2008-09-18FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Clarithromycin from Sandoz Inc, marking regulatory clearance for changes to this generic ant…
-
FDA approval · 2008-07-23FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cefdinir (CEFDINIR). The approval authorizes changes to the cefdi…
-
CLINICAL_TRIALS trial_result · 2008-07-23Clinical Trial Update: First Time in Man Trial for Friulimicin B [Phase 1]
This update reports that the first-in-man Phase 1 trial of Friulimicin B has been terminated, with MerLion Pharmaceuticals GmbH studying ind…
-
FDA approval · 2008-06-12FDA Approved: CEFDINIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA has approved a supplemental application for cefdinir (Teva), updating the labeling for the product. This action confirms a labeling-rela…
-
FDA approval · 2008-06-11FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for CEFDINIR (cefdinir) from Lupin Pharmaceuticals, indicating an expanded approval for this antibio…
-
CLINICAL_TRIALS trial_result · 2008-05-20Clinical Trial Update: A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults [Phase 3]
Phase 3 trial of Azithromycin SR for mild to moderate community-acquired pneumonia in Japanese adults has completed.
-
FDA approval · 2008-01-07FDA Approved: CEFDINIR — Original Application (BluePoint Laboratories)
FDA approves an Abbreviated New Drug Application for cefdinir from BluePoint Laboratories, indicating the availability of a generic cefdinir…
-
FDA approval · 2007-12-14FDA Approved: CEFDINIR — Original Application (Aurobindo Pharma Limited)
FDA approved a generic cefdinir (CEFDINIR) from Aurobindo Pharma Limited under an Original Application (ANDA) for acute otitis media, acute …
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: Ketek in CAP / AECB in Ambulatory Adult Patients [Phase 4]
Phase 4 clinical trial update of Ketek (telithromycin) in ambulatory adults with community-acquired pneumonia or acute exacerbations of chro…